echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Study of Nervous System > eClinicalMedicine︱Wang Qing's team reports Parkinson's disease dementia-related index quantification: quantitative EEG, serum metabolism and inflammation

    eClinicalMedicine︱Wang Qing's team reports Parkinson's disease dementia-related index quantification: quantitative EEG, serum metabolism and inflammation

    • Last Update: 2022-09-09
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com


    Written by Liu Hailing, Wang Qing

    Editor in charge ︱ Wang Sizhen

    Editor︱Yang Binwei


    Parkinson's disease (PD) is a common neurodegenerative disease in middle-aged and elderly people



    Quantitative electroencephalography (QEEG) is a non-invasive, high temporal resolution and objective diagnostic method that can rapidly assess transient neuronal and synaptic function and may be sensitive to early neurodegenerative changes [2]



    A meta-analysis pointed out [4] that Hs-CRP, as a common peripheral inflammatory marker, can enhance the permeability of the blood-brain barrier (BBB), mediate the occurrence and progression of PD through the immune system, and predict the prognosis of PD.



    On July 29, 2022, the team of Professor Wang Qing from Pearl River Hospital of Southern Medical University published a meta-analysis article on repetitive transcranial magnetic stimulation (rTMS) in the international authoritative journal eClinicalMedicine (Part of The Lancet Discovery Science) (IF: 17.




    To explore the differences of QEEG indexes in PD patients with or without dementia, the authors retrospectively analyzed quantitative EEG data of PD patients in Zhujiang Hospital from 2018-7-1 to 2021-7-1



    Figure 1 Flowchart

    (Source: Hailing Liu, et al.



    1.


    In the EEG examination room, the subjects were kept quiet, eyes closed, and a comfortable sitting position after eating, and the same physician performed EEG monitoring
    .

    The EEG signal with a stable baseline and no obvious artifacts was selected as the analysis object, and no other filtering was added except the 50 Hz notch
    .

    The spectrum analysis of EEG signals was carried out on Matlab 13.
    0 software, and Fourier transform was used to convert EEG time-domain signals into frequency-domain signals.
    4 to 8 Hz), alpha band (8 to 13 Hz), and beta band (13 to 30 Hz)
    .

    The authors calculated the absolute power values ​​and the fast-slow power ratio of different frequency bands in the whole brain area, frontal area, parietal area, central area, occipital area, and temporal area: (δ + θ)/(α + β)
    .

    In addition, the differences in the frequency of alpha peaks in the occipital region of each group were also calculated
    .

    Using analysis of covariance with age as a covariate, the authors compared the whole-brain power spectra of different frequency bands in different groups of PDD, PD-ND, and HC, and found significant between-group abnormalities in the delta frequency band (P = 0.
    000)
    .

    The fast-slow frequency band ratio, delta frequency band and alpha peak frequency in the occipital area are all characteristic indicators of EEG slowing.
    Across brain regions, the slow-wave power of PDD was higher, while PD-ND did not differ compared to HC (Fig.
    2)
    .

    Figure 2 Quantitative EEG slowing in patients with Parkinson's dementia

    (Source: Hailing Liu, et al.
    , eclinicalMedicine, 2022)


    By comparing the topographic maps of different frequency bands between the three groups, the authors found that the delta spectral power was highest in PDD patients, especially in the frontal lobe region, and the difference was statistically significant
    .

    In the theta (4-8 Hz) power spectral topography, significant differences were only found in frontal and temporal regions in PDD patients
    .

    Comparing the peak frequencies in the occipital region of the three groups, in the occipital leads O1 and O2, the PDD peak frequency was the lowest, followed by PD-ND patients and HC (Fig.
    3)
    .

    Figure 3 Brain topographic map and comparison of peak frequency in occipital area

    (Source: Hailing Liu, et al.
    , eclinicalMedicine, 2022)

    2.
    Serum inflammatory and metabolic markers of the difference between PDD and PD-ND

    The Mann–Whitney U test univariate analysis was performed on the included serum markers between the two groups of patients with PDD and PD-ND, and it was found that HDL-C (P=0.
    002), GLU (P=0.
    013), Cys-C (P=0.
    013) = 0.
    003), Hs-CRP (P=0.
    001) and ESR (P=0.
    006) in PDD patients were significantly higher than those in PD-ND group, while SOD (P=0.
    379), UA (P=0.
    050), Chol (P=0.
    379) ), LDL-C (P=0.
    569), NEU% (P=0.
    061), MON% (P=0.
    153), LYM% (P=0.
    084) had no difference between the two groups
    .

    The univariate analysis indicators of differences were included in logistic regression, and the results showed that HDL-C (OR=0.
    186, P=0.
    030) and Hs-CRP (OR=2.
    856, P=0.
    015) were associated with PDD
    .

    3.
    Correlation between quantitative EEG indicators and serum inflammatory metabolic indicators

    Since the frontal region delta power was most significantly different in PPD and PD-ND, the authors examined the correlation between the absolute value of the frontal region delta power and the difference in serum inflammation and metabolic indicators
    .

    The results showed that the absolute value of frontal delta power was negatively correlated with MMSE scores, HDL-C and SOD levels in PD patients, and positively correlated with Hs-CRP levels (Figure 4)
    .

    Figure 4.
    Correlations between QEEG indicators and disease severity, inflammation, and metabolic indicators

    (Source: Hailing Liu, et al.
    , eclinicalMedicine, 2022)

    4.
    The significance of QEEG, inflammatory and metabolic indicators ROC curve in predicting PDD

    Quantitative EEG, inflammatory, and metabolic indicators that assessed differences in ROC curves were used to identify the significance of PDD and PD-ND, and the differences were statistically significant (Fig.
    5-A)
    .

    The ROC curve after adjusting for age, the difference was still statistically significant (Fig.
    5-B)
    .

    The AUC of the absolute value of delta power in the frontal region (blue curve) was 0.
    747, the AUC of Hs-PCR was 0.
    771 (orange curve), and the AUC of HDL-C was 0.
    712 (green curve)
    .

    The combined AUC of frontal-delta power absolute, Hs-PCR and HDL-C (red curve) was 0.
    801
    .

    Figure 5.
    ROC curve evaluation of quantitative EEG, inflammation, and metabolic markers for the identification of PDD and PD-ND

    ((Source: Hailing Liu, et al.
    , eclinicalMedicine, 2022)

    Conclusions and Discussions, (Future) Inspirations and Prospects In conclusion, in Parkinson's disease (PD) patients, the authors found that quantitative electroencephalogram (QEEG) indicators were correlated with serum inflammatory and metabolic indicators; The index is related to the severity of Parkinson's dementia (PDD); the combination of QEEG index with HDL-C and Hs-CRP may be one of the auxiliary and effective means to assess PDD
    .

    The authors' current findings suggest that peripheral inflammatory, metabolic markers may be involved in the pathogenesis of cognitive impairment and EEG slowing in PDD
    .

    In future clinical trials, the authors will further investigate the association of QEEG with neuroinflammation and other metabolic markers in patients with PDD
    .

    Original link: https://doi.
    org/10.
    1016/j.
    eclinm.
    2022.
    101615

    Corresponding author: Wang Qing

    (Photo courtesy of: Wang Qing Laboratory, Pearl River Hospital, Southern Medical University)

    About the author (swipe up and down to read) 

    Director of Neurology Department, Zhujiang Hospital, Southern Medical University, Associate Editor of Frontiers in Aging Neuroscience (5.
    7), Guest Editor of Journal of Clinical Medicine (4.
    96), Journal of Aging and Disease (9.
    97), Experimental Neurology (5.
    6), Frontiers in Cellular Neuroscience (6.
    1) The editorial board has undertaken 973, major research and development plan sub-projects, and published more than 80 SCI papers in more than 40 projects including the National Natural Science Foundation of China (5 aspects).
    IF:17), Brain (15.
    3), Progress in Neurobiology (10.
    8), EBioMedicine (11.
    2), Brief Bioinform (13.
    99), Move Disord (10.
    8), more than 40 articles > 5 points, he cited 2800+ times, H-index 28
    .

    Selected past articles

    [1] PNAS︱Li Gang's research group draws the developmental pattern and regionalization map of infant cerebral cortex surface area

    【2】Front Mol Neurosci︱Chen Jun's research group revealed that secondary nerve injury and neuroinflammation in the spinal dorsal horn mediate thalamic hemorrhagic post-stroke pain

    【3】Aging Cell︱Xiao Jianhui's team reported a potential anti-aging drug: Ganoderma lucidum D activates the CaM/CaMKII/NRF2 signaling axis to delay stem cell aging

    【4】Mol Psychiatry︱Zheng Wei/Liao Fang team work together to reveal early events of white matter lesions in vascular cognitive impairment and dementia

    [5] Cell Rep | Xing Dajun's research group published a paper revealing the differences between the primary visual cortex of macaques and convolutional neural networks in integrating visuospatial information

    【6】Neuron|Hu Yang's group revealed a large number of genes that promote optic nerve regeneration and their significant neuroprotective effects in glaucoma mice

    【7】Cereb Cortex︱Zhang Yuxuan's research group reveals the neurophysiological evidence of task modulation in speech processing

    [8] Trends Cogn Sci︱Qiu Jiang's team writes opinion articles on creative problem solving in knowledge-rich fields

    【9】Front Aging Neurosci︱Hongmei Yu’s team constructed a hierarchical multi-classification diagnosis framework for AD based on imaging features and clinical information

    【10】J Neurosci︱Jin Mingyue / Guangchang Shinji's team revealed that α-Syn and tau play an important synergistic physiological function during brain development

    Recommended high-quality scientific research training courses

    [1] Symposium on Single-Cell Sequencing and Spatial Transcriptomics Data Analysis (August 27-28, Tencent Online Conference)

    【2】Training course︱R language clinical prediction biomedical statistics special training

    [3] Workshop on Metagenomics and Metabolomics R Language Analysis and Visualization (Tencent Conference on August 27)

    Forum/Seminar Preview

    【1】Forum Preview︱Brain·Machine Intelligence Fusion——Let the brain connect to the future, the brain science theme forum is the first time!

    Welcome to "Logical Neuroscience" [1] Talent Recruitment︱"Logical Neuroscience" is looking for article interpretation/writing positions (part-time online, online office)

    References (swipe up and down to read) 

    1.
    Zhu S, Li H, Xu X, et al.
    The Pathogenesis and Treatment of Cardiovascular Autonomic Dysfunction in Parkinson's Disease: What We Know and Where to Go.
    Aging and disease 2021;12:1675-1692.

    2.
    Schjonning Nielsen M, Simonsen AH, Siersma V, et al.
    Quantitative Electroencephalography Analyzed by Statistical Pattern Recognition as a Diagnostic and Prognostic Tool in Mild Cognitive Impairment: Results from a Nordic Multicenter Cohort Study.
    Dement Geriatr Cogn Dis Extra 2018;8:426-438.

    3.
    Garn H, Coronel C, Waser M, Caravias G, Ransmayr G.
    Differential diagnosis between patients with probable Alzheimer's disease, Parkinson's disease dementia, or dementia with Lewy bodies and frontotemporal dementia, behavioral variant, using quantitative electroencephalographic features.
    J Neural Transm (Vienna) 2017;124:569-581.

    4.
    Qiu X, Xiao Y, Wu J, Gan L, Huang Y, Wang J.
    C-Reactive Protein and Risk of Parkinson's Disease: A Systematic Review and Meta-Analysis.
    Frontiers in neurology 2019;10:384.

    5.
    Fang F, Zhan Y, Hammar N, et al.
    Lipids, Apolipoproteins, and the Risk of Parkinson Disease.
    Circulation research 2019;125:643-652.

    6.
    Park JH, Lee CW, Nam MJ, et al.
    Association of High-Density Lipoprotein Cholesterol Variability and the Risk of Developing Parkinson Disease.
    Neurology 2021;96:e1391-e1401.

    7.
    Rozani V, Gurevich T, Giladi N, et al.
    Higher serum cholesterol and decreased Parkinson's disease risk: A statin-free cohort study.
    Mov Disord 2018;33:1298-1305.

    8.
    Colom-Cadena M, Spires-Jones T, Zetterberg H, et al.
    The clinical promise of biomarkers of synapse damage or loss in Alzheimer's disease.
    Alzheimers Res Ther 2020;12:21.

    9.
    Caviness JN, Lue LF, Hentz JG, et al.
    Cortical phosphorylated alpha-Synuclein levels correlate with brain wave spectra in Parkinson's disease.
    Mov Disord 2016;31:1012-1019.

    10.
    Balter LJ, Bosch JA, Aldred S, et al.
    Selective effects of acute low-grade inflammation on human visual attention.
    Neuroimage 2019;202:116098.

    11.
    Emre M, Aarsland D, Brown R, et al.
    Clinical diagnostic criteria for dementia associated with Parkinson's disease.
    Mov Disord 2007;22:1689-1707; quiz 1837.


    End of this article

    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.